New study shows medication abortion without ultrasound to be safe Dr. Kamal Kant Kohli5 July 2024 8:00 PM ISTResearchers compared patients who received care remotely to those who got ultrasounds and found no differences in outcomes. Medication abortion...
Fingerprints shall predict regularity of TB patients on antitubercular drugs in future, says study Dr. Kamal Kant Kohli5 July 2024 7:30 PM ISTA fingerprint may soon be all a doctor needs to check whether tuberculosis patients are taking their antibiotics-thanks to a new study led by the...
Hetero Healthcare Ltd Launches Hetran- A New Era in Acid Blocker Therapy MD Brand Connect5 July 2024 11:30 AM ISTUnderstanding the growing need for effective gastric acid related diseases treatment, Hetero Healthcare Ltd, one of India's leading generic...
Intravenous tolvaptan equally safe and effective as oral formulation in severe acute heart failure patients: Study Medha Baranwal5 July 2024 9:45 AM ISTJapan: In a new study focusing on the management of acute decompensated heart failure (ADHF), researchers have compared the efficacy and safety of...
Semaglutide Shines in Kidney Health Across Diabetes Patients: Study Highlights Consistency and Potential Medha Baranwal5 July 2024 9:15 AM ISTGermany: A recent clinical trial, known as the FLOW trial, has provided significant insights into treating type 2 diabetes and chronic kidney disease...
Antiseizure medications can produce life-threatening reactions, claims study Dr. Kamal Kant Kohli4 July 2024 9:15 PM ISTTargeted blood tests, asking patients about risk factors, and dose modifications can lessen the risk of potentially fatal reactions to antiseizure...
Popular weight loss drug Semaglutide linked to uncommon blinding condition, reveals JAMA study Dr. Kamal Kant Kohli4 July 2024 7:30 PM ISTInvestigators at Mass Eye and Ear have found in a new study have found that patients who were prescribed semaglutide for diabetes or weight loss...
Zydus Lifesciences BP lowering drug receives USFDA tentative nod Ruchika Sharma4 July 2024 4:46 PM ISTAhmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to market...
Semaglutide effects greater weight loss in women than men with HF, improves HF symptoms in both sexes, suggests study Dr. Kamal Kant Kohli4 July 2024 9:00 AM ISTSemaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of...
New Genetic Study Highlights Oxytocin's Role in Treating Obesity and Postnatal Depression Anshika Mishra4 July 2024 8:15 AM ISTScientists have identified a gene that, when missing or impaired, can cause obesity, behavioral problems and, in mothers, postnatal depression. The...
FDA approves another drug for treatment of adults with early symptomatic Alzheimer's disease Dr. Kamal Kant Kohli3 July 2024 8:30 PM ISTThe US Food and Drug Administration has approved aother drug donanemab (Kisunla) for treatment of adults with early symptomatic Alzheimer's disease...
Lipoprotein(a) Levels Linked to Increased Risk of In-Stent Restenosis Post-PCI: New Study Reveals Medha Baranwal3 July 2024 10:00 AM ISTUSA: Recent research has shed light on the connection between lipoprotein(a) levels and the long-term risk of in-stent restenosis (ISR) following...
